The Rapid Acceleration of Diagnostics Technology (RADx® Tech) Advancing Cures and Therapies and ending ENDOmetriosis diagnostic delays (ACT ENDO) Challenge, led by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) is awarding $3.0 million in prizes to accelerate the development of innovative technologies for the diagnosis of endometriosis.

Innovators may include, but are not limited to, teams of individuals, start-ups, businesses, non-profit organizations, and academic research institutions. Prizes will be awarded following the successful completion of each phase of the challenge. 

The deadline for submission is October 11th, 2024. To learn more about the challenge and the application criteria visit the challenge website here.